What Are The Chances Of Boston Scientific Corp. (NYSE: BSX) Becoming A Clear Buy?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

As a NYSE listed company, BSX falls under the Healthcare sector while operating within the Medical Devices industry segment. The current market capitalization of Boston Scientific Corp. is $109.45B. A total of 4.49 million shares were traded on the day, compared to an average of 6.29M shares.

In the most recent transaction, Thepaut Eric Francis Yves sold 12,931 shares of BSX for 74.14 per share on May 10 ’24. After the transaction, the EVP & Pres, Eur, Mid-East, Afr now owns 31,422 company shares. In a previous transaction on May 07 ’24, Dockendorff Charles J sold 3,946 shares at 72.70 per share. BSX shares that Director owns now total 0.

Among the insiders who sold shares, Sorenson John Bradley disposed of 17,587 shares on May 01 ’24 at a per-share price of $71.50. This resulted in the EVP, Global Operations holding 50,638 shares of BSX after the transaction. In another insider transaction, Carruthers Wendy sold 6,983 shares at $71.47 per share on May 01 ’24. Company shares held by the EVP, Human Resources now total 48,348.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, BSX has a high of $74.39 and a low of $48.35.

As of this writing, BSX has an earnings estimate of $0.58 per share for the current quarter. EPS was calculated based on a consensus of 26.0 estimates, with a high estimate of $0.59 per share and a lower estimate of $0.57. The company reported an EPS of $0.53 in the last quarter

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. BSX’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $9.45B in debt and $4.27B in liabilities at the time. Its Book Value Per Share was $13.56, while its Total Shareholder’s Equity was $16.62B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BSX is Buy with a score of 4.71.

Most Popular

Related Posts